Published in
Elsevier, EBioMedicine, (86), p. 104322, 2022
DOI: 10.1016/j.ebiom.2022.104322
Links
Tools
Safety and efficacy of four drug regimens versus standard-of-care for the treatment of symptomatic outpatients with COVID-19: A randomised, open-label, multi-arm, phase 2 clinical trial
Journal article published in 2022 by
Nomathemba Chandiwana 
,
Chelsea Kruger,
Hilary Johnstone,
Mohamed Farouk Chughlay,
Chung Ju,
Byungsu Kim,
Yengiwe Dineka,
Sarah Arbe-Barnes,
Robert Miller,
Andrew Owen,
Andrew Hill,
Daniel Windgassen,
Nada Abla,
Anne Claire Marrast,
Stephan Duparc
and other authors.
,
Chelsea Kruger,
Hilary Johnstone,
Mohamed Farouk Chughlay,
Chung Ju,
Byungsu Kim,
Yengiwe Dineka,
Sarah Arbe-Barnes,
Robert Miller,
Andrew Owen,
Andrew Hill,
Daniel Windgassen,
Nada Abla,
Anne Claire Marrast,
Stephan Duparc
and other authors.
This paper is made freely available by the publisher.
Full text: Download
Postprint:
archiving forbidden
Data provided by 